Conversely to most tumour types, magnetic resonance imaging (MRI) was rarely used for eye tumours. As recent technical advances have increased ocular MRI’s diagnostic value, various clinical applications have been proposed. This systematic review provides an overview of the current status of MRI in the clinical care of uveal melanoma (UM) patients, the most common eye tumour in adults. In total, 158 articles were included. Two- and three-dimensional anatomical scans and functional scans, which assess the tumour micro-biology, can be obtained in routine clinical setting. The radiological characteristics of the most common intra-ocular masses have been described extensively, enabling MRI to contribute to diagnoses. Additionally, MRI’s ability to non-invasively probe the tissue’s biological properties enables early detection of therapy response and potentially differentiates between high- and low-risk UM. MRI-based tumour dimensions are generally in agreement with conventional ultrasound (median absolute difference 0.5 mm), but MRI is considered more accurate in a subgroup of anteriorly located tumours. Although multiple studies propose that MRI’s 3D tumour visualisation can improve therapy planning, an evaluation of its clinical benefit is lacking. In conclusion, MRI is a complementary imaging modality for UM of which the clinical benefit has been shown by multiple studies.
7 November 2022 in Physics and Imaging in Radiation Oncology
Three-dimensional (3D) Magnetic Resonance Imaging (MRI) is increasingly used to complement conventional two-dimensional ultrasound in the assessment of tumour dimension measurement of uveal melanoma. However, the lack of definitions of the 3D measurements of these tumour dimensions hinders further adaptation of MRI in ocular radiotherapy planning. In this study, we composed 3D MR-based definitions of tumour prominence and basal diameter and compared them to conventional ultrasound. Tumours were delineated on 3DT2 and contrast-enhanced 3DT1 (T1gd) MRI for 25 patients. 3D definitions of tumour prominence and diameter were composed and evaluated automatically on the T1gd and T2 contours. Automatic T1gd measurements were compared to manual MRI measurements, to automatic T2 measurements and to manual ultrasound measurements. Prominence measurements were similar for all modalities (median absolute difference 0.3 mm). Automatic T1gd diameter measurements were generally larger than manual MRI, automatic T2 and manual ultrasound measurements (median absolute differences of 0.5, 1.6 and 1.1 mm respectively), mainly due to difficulty defining the axis of the largest diameter. Largest differences between ultrasound and MRI for both prominence and diameter were found in anteriorly located tumours (up to 1.6 and 4.5 mm respectively), for which the tumour extent could not entirely be visualized with ultrasound. The proposed 3D definitions for tumour prominence and diameter agreed well with ultrasound measurements for tumours for which the extent was visible on ultrasound. 3D MRI measurements generally provided larger diameter measurements than ultrasound. In anteriorly located tumours, the MRI measurements were considered more accurate than conventional ultrasound.
Purpose: Ellipsoid tumour models are used to approximate the tumour volume of uveal melanomas, as the conventionally used ultrasound does not provide a three‐dimensional visualization of the tumour. However, these models are a simplification of the actual tumour geometry. The aim of this study was to determine to what extent several of these frequently used ellipsoid tumour models accurately describe uveal melanoma volume.Methods: Tumours were delineated on contrast‐enhanced T1‐weighted MRI for 70 uveal melanoma patients. The MRI‐delineated volume was compared with three ellipsoid models, which used two‐dimensional measurements such as thickness and basal diameters as input: half ellipsoids with round (Vroundbase) or oval base (Vovalbase) and a paraboloid consisting of two parts, also incorporating the curvature of the eye wall (Vtwoparts).Results: Statistically significant relative differences between MRI‐delineated and model volume of 53 ± 32% (Vroundbase), 26 ± 24% (Vovalbase) and 15 ± 24% (Vtwoparts) were observed (p < 0.001). Tumour volume and shape did not influence the difference between the model volumes and MRI‐delineated tumour volume.Conclusion: All tumour models result in considerable systematic overestimations of tumour volume, with large variations in overestimation between patients. Adding the perpendicular basal diameter to the model decreases this variation. Although ellipsoid tumour models have been shown to be valuable on a group level, they should be used with caution for individual patients.
3 September 2024 in Investigative Ophthalmology & Visual Science
Purpose: Perfusion-weighted imaging (PWI; magnetic resonance imaging [MRI]) has been shown to provide valuable biological tumor information in uveal melanoma (UM). Clinically used semiquantitative methods do not account for tumor pigmentation and eye movement. We hypothesize that a quantitative PWI method that incorporates these, provides a more accurate description of tumor perfusion than the current clinical method. The aim of this study was to test this in patients with UM before and after radiotherapy. Methods: Perfusion-weighted 3T MRIs were retrospectively analyzed in 47 patients with UM before and after radiotherapy. Tofts pharmacokinetic modeling was performed to determine vascular permeability (Ktrans), extracellular extravascular space (ve), and reflux rate (kep). These were compared with semiquantitative clinical parameters including peak intensity and outflow percentage. Results: The effect of tumor pigmentation on peak intensity and outflow percentage was statistically significant (P < 0.01) and relative peak intensity was significantly different between melanotic and amelanotic tumors (1.5 vs. 1.9, P < 0.01). Before radiotherapy, median tumor Ktrans was 0.63 min−1 (range = 0.06–1.42 min−1), median ve was 0.23 (range = 0.09–0.63), and median kep was 2.3 min−1 (range = 0.6–5.0 min−1). After radiotherapy, 85% showed a decrease in Ktrans and kep (P < 0.01). Changes in tumor pigmentation before and after radiotherapy were small and not significant (median increase in T1 of 33 ms, P = 0.55). Conclusions: Quantitative PWI parameters decreased significantly after radiotherapy and can therefore can serve as an early biomarker for treatment response assessment. However, due to the nonsignificant changes in tumor pigmentation before and after radiotherapy, the current semiquantitative method appears to be sufficiently sensitive for detection of changes in tumor perfusion.
Purpose: To conduct an exploratory analysis of quantitative and semi-quantitative perfusion-weighted MRI (PWI) parameters across various intraocular lesions and assess their relationship with fluorescein angiography (FAG) features. Methods: Thirty-eight patients with twelve different diagnoses who underwent 3T dynamic contrast-enhanced MRI (DCE-MRI) of the eye were included, with diagnosis confirmed either by histopathology or clinical course of the disease. Tofts pharmacokinetic modelling was used to calculate K trans , v e , and k ep values. Semi-quantitative relative peak intensity and outflow percentage were derived from time-intensity curves and compared with quantitative parameters. FAG images were evaluated for blocking effects, pinpoint and diffuse leakages. Results: Median values of quantitative and semi-quantitative parameters varied across lesion types. Haemangiomas showed the highest K trans (median = 6.35 min − 1 ) and k ep (median = 3.8 min − 1 ). Uveal melanomas showed high K trans (median = 0.68 min − 1 ) and k ep (median = 2.45 min − 1 ) in comparison with choroidal naevi and metastases. Quantitative and semi-quantitative parameters showed significant correlation across all intensity groups (all R 2 > 0.36, all p < 0.04). The correlation between K trans and relative peak intensity differed for hypo- and isointense lesions versus hyperintense lesions (both p < 0.002). Statistical comparison between individual diagnoses was not possible due to limited sample size per diagnosis. Quantitative PWI parameters showed correspondence with FAG features. Conclusion: This study provided quantitative and semi-quantitative PWI parameters for various intraocular lesions. Semi-quantitative PWI parameters may provide comparable information on lesion vascularity when stratified by T1 signal intensity.
In recent years, eye-specific, high-resolution MRI protocols have become available for ocular tumours, enabling 3D tumour delineation. Despite these advances, ocular proton therapy typically still relies on model-based target volume definition. Therefore, the aim of this research was to compare model-based and delineation-based target volume definition for ocular tumours. Tumours were delineated for 70 uveal melanoma patients. From the delineated tumour base, polynomial models of different degrees were generated. Additionally, model variations with expanded base and added thickness were generated. Models were considered acceptable at a coverage level of 98% or a maximum underestimation of 0.4 mm. The best model for each patient was defined as the acceptable model with the smallest volume. For 69/70 patients, an acceptable tumour model could be generated, out of whom 12/69 needed an expansion of the tumour base or added tumour thickness to produce at least one acceptable model. At a coverage level of 98%, tumours were overestimated with 20.5% (5th-95th percentile: 5.7%-59.7%), corresponding to a median absolute surface distance of 0.42 mm. Irregularly shaped tumours showed larger overestimations than dome-shaped tumours (16.4% vs 36.6%, p < 0.001). Tumour models as used in ocular proton therapy treatment planning systems can achieve acceptable tumour coverage. However, to achieve this coverage, the tumour models overestimated the delineated tumour volume.